9% of patients had a complete response, and 60% of patients had a partial response
Understanding these mechanisms can help clinicians counsel patients appropriately and manage expectations during treatment initiation
By December 18, 2026, the Director of the Office of Management and Budget (OMB) is mandated to publish a comprehensive list of BCCs based on recommendations from the Department of Defense, the Justice Department, and Health and Human Services
Click link & in my bio and start your journey today
Currently 3 trials aimed to evaluate safety, tolerability, and efficacy of metformin in FXS patients are ongoing (ClinicalTrials.gov Identifier: NCT04141163, NCT03862950, NCT03479476)
Eliminate skin blemishes 21